KRAS Variants Are Associated With Survival Outcomes and Genomic Alterations in Biliary Tract Cancers.
Gelfer R, Gulla A, Kalvin HL, Song Y, Harding J, Abou-Alfa GK, O'Reilly EM, Park W, Chandwani R, Wei A, Kingham P, Drebin J, Balachandran V, D'Angelica M, Soares K, Gonen M, Jarnagin WR.
Gelfer R, et al. Among authors: wei a.
JCO Precis Oncol. 2024 Dec;8:e2400263. doi: 10.1200/PO.24.00263. Epub 2024 Dec 6.
JCO Precis Oncol. 2024.
PMID: 39642327